https://novapharmanews.com/eu/news/chmp-meeting-highlights-drug-approvals-april-2026 2026-05-23T22:00:21.358Z NovaPharmaNews en-GB 2026-05-23T08:00:52.594Z CHMP Meeting Highlights: Drug Approvals from May 2026 https://novapharmanews.com/uploads/articles/chmp-meeting-highlights-may-2026-drug-approvals.webp CHMP Meeting Highlights: Drug Approvals from May 2026 https://novapharmanews.com/us/news/eli-lilly-engage-acquisition-analysis 2026-05-23T22:36:10.853Z NovaPharmaNews en-US 2026-05-23T08:00:44.678Z Eli Lilly Acquires Engage for $202M: Market Analysis https://novapharmanews.com/uploads/articles/eli-lilly-engage-acquisition-analysis.webp Eli Lilly Acquires Engage for $202M: Market Analysis https://novapharmanews.com/us/news/krystal-biotech-q1-earnings-beat-catalysts-2026-2027 2026-05-23T23:13:02.934Z NovaPharmaNews en-US 2026-05-23T08:00:44.678Z Krystal Biotech Q1 Earnings Beat: Catalysts Ahead for 2026 & 2027 https://novapharmanews.com/uploads/articles/krystal-biotech-q1-earnings-beat-catalysts-2026-2027.webp Krystal Biotech Q1 Earnings Beat: Catalysts Ahead for 2026 & 2027 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-competitive-headwinds 2026-05-23T22:34:27.239Z NovaPharmaNews en-US 2026-05-23T08:00:44.678Z BioMarin's SWOT Analysis: Competitive Challenges Ahead rare disease https://novapharmanews.com/uploads/articles/biomarin-swot-analysis-rare-disease-competitive-headwinds.webp BioMarin's SWOT Analysis: Competitive Challenges Ahead https://novapharmanews.com/us/news/rfk-jr-drug-approval-speed-oncology 2026-05-23T23:13:00.363Z NovaPharmaNews en-US 2026-05-23T08:00:44.678Z RFK Jr.’s Muddled Claims on Drug Approval Speed in Oncology oncology https://novapharmanews.com/uploads/articles/rfk-jr-drug-approval-speed-oncology.webp RFK Jr.’s Muddled Claims on Drug Approval Speed in Oncology https://novapharmanews.com/us/news/fda-approves-17-drugs-continuous-manufacturing 2026-05-23T23:26:25.460Z NovaPharmaNews en-US 2026-05-23T08:00:44.678Z FDA Approves 17 Drugs with Continuous Manufacturing: Implications for Pharma https://novapharmanews.com/uploads/articles/fda-approves-17-drugs-continuous-manufacturing.webp FDA Approves 17 Drugs with Continuous Manufacturing: Implications for Pharma https://novapharmanews.com/eu/news/efpia-warns-access-gap-us-pricing-reforms 2026-05-23T23:12:20.605Z NovaPharmaNews en-GB 2026-05-23T08:00:44.678Z EFPIA Warns of Widening Access Gap Under US Pricing Reforms https://novapharmanews.com/uploads/articles/efpia-warns-access-gap-us-pricing-reforms.webp EFPIA Warns of Widening Access Gap Under US Pricing Reforms https://novapharmanews.com/eu/news/european-biotechs-cell-gene-therapy-manufacturing 2026-05-23T23:29:24.388Z NovaPharmaNews en-GB 2026-05-23T08:00:44.678Z European Biotechs Innovate in Cell and Gene Therapy Manufacturing gene therapy https://novapharmanews.com/uploads/articles/european-biotechs-cell-gene-therapy-manufacturing.webp European Biotechs Innovate in Cell and Gene Therapy Manufacturing https://novapharmanews.com/eu/news/eu-lawmakers-critical-medicines-act-deal 2026-05-23T23:25:18.702Z NovaPharmaNews en-GB 2026-05-23T08:00:44.678Z EU Lawmakers Reach Provisional Deal on Critical Medicines Act: Market Analysis https://novapharmanews.com/uploads/articles/eu-lawmakers-critical-medicines-act-deal.webp EU Lawmakers Reach Provisional Deal on Critical Medicines Act: Market Analysis https://novapharmanews.com/apac/news/clinical-trials-day-2026-research-rising-oncology 2026-05-23T23:12:51.959Z NovaPharmaNews en-AU 2026-05-23T08:00:44.678Z Clinical Trials Day 2026: Research Rising in Oncology oncology https://novapharmanews.com/uploads/articles/clinical-trials-day-2026-research-rising-oncology.webp Clinical Trials Day 2026: Research Rising in Oncology https://novapharmanews.com/apac/news/fosun-pharma-aribio-option-agreement 2026-05-23T23:13:03.763Z NovaPharmaNews en-AU 2026-05-23T08:00:44.678Z Fosun Pharma and AriBio: Strategic Option Agreement Insights https://novapharmanews.com/uploads/articles/fosun-pharma-aribio-option-agreement.webp Fosun Pharma and AriBio: Strategic Option Agreement Insights https://novapharmanews.com/apac/news/crinetics-pharmaceuticals-jefferies-global-healthcare-2026 2026-05-23T22:39:02.656Z NovaPharmaNews en-AU 2026-05-23T08:00:44.678Z Crinetics Pharmaceuticals to Join Jefferies Global Healthcare Conference 2026 https://novapharmanews.com/uploads/articles/crinetics-pharmaceuticals-jefferies-global-healthcare-2026.webp Crinetics Pharmaceuticals to Join Jefferies Global Healthcare Conference 2026 https://novapharmanews.com/eu/news/serb-pharma-acquires-idefirix-rights 2026-05-23T23:27:18.629Z NovaPharmaNews en-GB 2026-05-22T08:17:18.618Z SERB Pharma Acquires Idefirix Rights from Hansa Idefirix https://novapharmanews.com/uploads/articles/serb-pharma-acquires-idefirix-rights.webp SERB Pharma Acquires Idefirix Rights from Hansa https://novapharmanews.com/apac/news/kelun-merck-lung-cancer-combo-china-trial 2026-05-23T21:59:56.079Z NovaPharmaNews en-AU 2026-05-22T08:17:18.618Z Kelun and Merck's Lung Cancer Combo Shows Promise in China oncology, lung cancer https://novapharmanews.com/uploads/articles/kelun-merck-lung-cancer-combo-china-trial.webp Kelun and Merck's Lung Cancer Combo Shows Promise in China https://novapharmanews.com/apac/news/ildong-pharmaceutical-stock-earnings-pipeline-insights 2026-05-23T22:25:44.984Z NovaPharmaNews en-AU 2026-05-22T08:17:18.618Z Ildong Pharmaceutical Stock: Earnings and Pipeline Insights https://novapharmanews.com/uploads/articles/ildong-pharmaceutical-stock-earnings-pipeline-insights.webp Ildong Pharmaceutical Stock: Earnings and Pipeline Insights https://novapharmanews.com/eu/news/teva-olan-ema-acceptance 2026-05-23T22:12:33.432Z NovaPharmaNews en-GB 2026-05-22T08:17:18.618Z Teva's Olan Application Accepted by EMA: What It Means for Pharma Olan https://novapharmanews.com/uploads/articles/teva-olan-ema-acceptance.webp Teva's Olan Application Accepted by EMA: What It Means for Pharma https://novapharmanews.com/eu/news/mhra-consultation-rare-disease-therapy 2026-05-23T22:13:00.218Z NovaPharmaNews en-GB 2026-05-22T08:17:18.618Z MHRA Consultation on Rare Disease Therapy Draft Guidance rare disease https://novapharmanews.com/uploads/articles/mhra-consultation-rare-disease-therapy.webp MHRA Consultation on Rare Disease Therapy Draft Guidance https://novapharmanews.com/us/news/liminatus-acquires-innocsai-320m-car-t-bet 2026-05-23T23:13:01.506Z NovaPharmaNews en-US 2026-05-22T08:17:18.618Z Liminatus Acquires InnocsAI: A $320M CAR-T Bet https://novapharmanews.com/uploads/articles/liminatus-acquires-innocsai-320m-car-t-bet.webp Liminatus Acquires InnocsAI: A $320M CAR-T Bet https://novapharmanews.com/us/news/aptar-pharma-fda-research-contract-progress 2026-05-23T23:13:19.063Z NovaPharmaNews en-US 2026-05-22T08:17:18.618Z Aptar Pharma Advances FDA-Funded Research Contract for Drug Approvals https://novapharmanews.com/uploads/articles/aptar-pharma-fda-research-contract-progress.webp Aptar Pharma Advances FDA-Funded Research Contract for Drug Approvals https://novapharmanews.com/us/news/fda-in-flux-may-2026-drug-approvals-update 2026-05-23T23:25:19.955Z NovaPharmaNews en-US 2026-05-22T08:17:18.618Z FDA in Flux: May 2026 Drug Approvals Update https://novapharmanews.com/uploads/articles/fda-in-flux-may-2026-drug-approvals-update.webp FDA in Flux: May 2026 Drug Approvals Update https://novapharmanews.com/us/news/best-cancer-stocks-2026-investment 2026-05-23T23:27:19.574Z NovaPharmaNews en-US 2026-05-22T08:17:18.618Z Best Cancer Stocks for 2026: Investment Insights oncology, cancer https://novapharmanews.com/uploads/articles/best-cancer-stocks-2026-investment.webp Best Cancer Stocks for 2026: Investment Insights https://novapharmanews.com/us/news/fda-fast-track-oncology-drugs-april-2026 2026-05-23T17:13:44.307Z NovaPharmaNews en-US 2026-05-22T08:17:18.618Z FDA Fast Track Designation for Oncology Drugs: April 2026 Insights oncology https://novapharmanews.com/uploads/articles/fda-fast-track-oncology-drugs-april-2026.webp FDA Fast Track Designation for Oncology Drugs: April 2026 Insights https://novapharmanews.com/us/news/fda-guidance-animal-testing-alternatives-concerns 2026-05-23T22:12:52.748Z NovaPharmaNews en-US 2026-05-22T08:17:18.618Z FDA's Guidance on Animal Testing Alternatives: Industry Concerns https://novapharmanews.com/uploads/articles/fda-guidance-animal-testing-alternatives-concerns.webp FDA's Guidance on Animal Testing Alternatives: Industry Concerns